acute myeloid leukemia

You have access
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk
SHEEHYUN KIM, SUNG-SOO YOON, JUNSHIK HONG, DONG-YEOP SHIN, YOUNGIL KOH, JA MIN BYUN and INHO KIM

Anticancer Research May 2020, 40 (5) 2917-2924; DOI: https://doi.org/10.21873/anticanres.14269
You have access
The Role of Anthracyclines in Acute Myeloid Leukemia Consolidation
JA MIN BYUN, JEONG-OK LEE, KOUNG JIN SUH, JIYUN LEE, DONG-YEOP SHIN, YOUNGIL KOH, JUNSHIK HONG, SOO-MEE BANG, INHO KIM and SUNG-SOO YOON

Anticancer Research January 2020, 40 (1) 357-366; DOI: https://doi.org/10.21873/anticanres.13960
You have access
Synergistic Antioncogenic Activity of Azacitidine and Curcumin in Myeloid Leukemia Cell Lines and Patient Samples
IVÁN MARTÍN, BLANCA NAVARRO, CARLOS SOLANO, MARISA CALABUIG, JUAN CARLOS HERNÁNDEZ-BOLUDA, PAULA AMAT, MARÍA JOSÉ REMIGIA, FRANCISCA GARCÍA, EVA VILLAMÓN and MAR TORMO

Anticancer Research September 2019, 39 (9) 4757-4766; DOI: https://doi.org/10.21873/anticanres.13659
You have access
The Combination of Flavokawain B and Daunorubicin Induces Apoptosis in Human Myeloid Leukemic Cells by Modifying NF-κB
JAE JIN LEE, KYUNG-NAM KOH, CHAN-JEOUNG PARK, SEONGSOO JANG, HO JOON IM and NAYOUNG KIM

Anticancer Research May 2018, 38 (5) 2771-2778;
You have access
Continuation of a Levonorgestrel Intrauterine Device During Hematopoietic Stem Cell Transplant: A Case Report
PAULA C. BRADY, ROBERT J. SOIFFER and ELIZABETH S. GINSBURG

Anticancer Research April 2017, 37 (4) 1985-1987;
You have access
Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene, SATB1, Resulting from a t(3;5)(p24;q14) Chromosomal Translocation in Acute Myeloid Leukemia
SYNNE TORKILDSEN, MARTA BRUNETTI, LUDMILA GORUNOVA, SIGNE SPETALEN, KLAUS BEISKE, SVERRE HEIM and IOANNIS PANAGOPOULOS

Anticancer Research February 2017, 37 (2) 693-698;
You have access
Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia
SUSAN K. WOELICH, JAMES T. BRAUN, MARTIN W. SCHOEN, RESHMA RAMLAL, CARL E. FRETER, PAUL J. PETRUSKA and JACK M. LIONBERGER

Anticancer Research February 2017, 37 (2) 713-717;
You have access
Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission
MICHAL KARAS, KATERINA STEINEROVA, DANIEL LYSAK, MARCELA HRABETOVA, ALEXANDRA JUNGOVA, JIRI SRAMEK, PAVEL JINDRA, JIRI POLIVKA and LUBOS HOLUBEC

Anticancer Research October 2016, 36 (10) 5487-5498;
You have access
Predictors of Survival in Acute Myeloid Leukemia by Treatment Modality
SAMIP MASTER, RICHARD MANSOUR, SRINIVAS S. DEVARAKONDA, ZHENZHEN SHI, GLENN MILLS and RUNHUA SHI

Anticancer Research April 2016, 36 (4) 1719-1727;
You have access
Up-regulation of PER3 Expression Is Correlated with Better Clinical Outcome in Acute Leukemia
MING-YU YANG, PAI-MEI LIN, HUI-HUA HSIAO, JUI-FENG HSU, HUGO YOU-HSIEN LIN, CHENG-MING HSU, I-YA CHEN, SHENG-WEN SU, YI-CHANG LIU and SHENG-FUNG LIN

Anticancer Research December 2015, 35 (12) 6615-6622;

Main menu

User menu

Search

acute myeloid leukemia

Pages